DOCSLIB.ORG

Detection of Cbfß/MYH11 Fusion Transcripts in Patients with Inv(16) Acute Myeloid Leukemia After Allogeneic Bone Marrow Or Peri

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Detection of Cbfß/MYH11 Fusion Transcripts in Patients with Inv(16) Acute Myeloid Leukemia After Allogeneic Bone Marrow Or Peri Bone Marrow Transplantation, (1998) 21, 159–166 1998 Stockton Press All rights reserved 0268–3369/98 $12.00 Detection of CBFb/MYH11 fusion transcripts in patients with inv(16) acute myeloid leukemia after allogeneic bone marrow or peripheral blood progenitor cell transplantation AH Elmaagacli1, DW Beelen1, M Kroll1, S Trzensky1, C Stein2 and UW Schaefer1 Departments of 1Bone Marrow Transplantation, and 2Department of Forensic Medicine, University Hospital of Essen, Essen, Germany Summary: Keywords: AML; inv(16); CBFb/MYH11; MRD; BMT We evaluated the occurrence of the CBFb/MYH11 fusion transcripts by PCR analysis in 10 patients with inv(16)(p13;q22) acute myeloid leukemia (AML) who Acute myelomonocytic leukemia with bone marrow eosino- underwent allogeneic bone marrow transplantation philia (AML-M4Eo), according to the French–American– (BMT) (n = 5), peripheral blood progenitor cell trans- British (FAB) classification, is a distinct subtype of AML. plantation (PBPCT) (n = 3), or autologous transplan- AML-M4Eo is often associated with rearrangements of tation (n = 2). In addition to the analysis of minimal chromosome 16, mostly involving 16p13 and 16q22, lead- residual disease (MRD), the chimerism status of patients ing either to a pericentric inversion, inv(16)(p13q22) or, after allogeneic transplant was studied by PCR. The less commonly, to a translocation between the homologous CBFb/MYH11 fusion trancript was not detectable in six chromosomes, t(16;16)(p13;q22). The pericentric inversion of seven patients who remained in remission after allo- inv(16)(p13q22) is one of the most frequently occurring geneic BMT or PBPCT. Two of these patients in chromosomal rearrangements detected in this neoplasm, remission were monitored for 50 months and 64 months which has been reported to account for approximately 16% post-BMT. One patient in remission was PCR-positive of all AML.1–3 for CBFb 3 months post-BMT in a single BM sample, The breakpoints involved in the inv(16) have recently but not in a simultaneously examined blood sample, been cloned and shown to involve the core binding factor suggesting that analyses from BM samples are more b-gene (CBFb) on 16q22 and the smooth muscle heavy sensitive than those from blood samples. Sequential chain (MYH11) on 16p13. The formation of the chimeric PCR assays performed 6 and 12 months post-BMT CBFb/MYH11 fusion gene results in the disruption of the obtained from the same patient were negative. Another normal interaction of the transcription factor complex a, b, patient with a positive PCR assay 3 months post-allo- and ETS.3 geneic PBPCT, remained PCR positive for the Patients with AML-M4Eo with inv(16)(p13q22) appear CBFb/MYH11 fusion transcript when tested 6 months to have a high response rate to induction chemotherapy and post-PBPCT. A chimerism analysis by PCR revealed a a favorable prognosis, but relapse of AML after chemo- mixed chimerism status in this patient. He relapsed 7 therapy remains a major cause of treatment failure. Allo- months post-transplant. Before transplant, in all nine geneic bone marrow transplantation (BMT) has become an patients who were in complete remission of AML (eight effective treatment modality for patients with hematological patients in 1CR, one patient in 2CR), the CBFb/MYH11 malignancies. Patients with AML in remission who transcript was detectable. In one patient in relapse, the undergo allogeneic BMT have a significantly lower risk of fusion transcript was not only detectable in blood and relapse than their counterparts treated with chemotherapy bone marrow, but also in a cerebrospinal fluid sample alone. On the other hand allogeneic BMT is associated with prior to transplant. Two patients who received autolog- more treatment-related mortality than autologous BMT or ous BMT were monitored for CBFb/MYH11 transcripts chemotherapy alone. 3 months after BMT. The CBFb/MYH11 was detected Several reports suggest that the CBFb/MYH11 fusion in these patients. Both patients subsequently relapsed 3 mRNA can often be detected in patients in long-term months and 23 months post-autologous BMT. The remission after chemotherapy.4–7 To date, other than single results study show that analysis of the CBFb/MYH11 case reports, studies of the detection of the CBFb/MYH11 fusion transcript by PCR seems to be a suitable method fusion transcripts after allogeneic BMT do not exist.7,8 for monitoring minimal residual disease in AML The aim of the present study was to determine if patients with inv (16). CBFb/MYH11 fusion transcripts can be detected in patients treated with allogeneic BMT (n = 5), allogeneic peripheral blood progenitor cell transplantation (PBPCT) (n = 3), or Correspondence: Dr AH Elmaagacli, Department of Bone Marrow Trans- = plantation, University Hospital of Essen, Hufelandstr. 55, 45122 Essen, autologous BMT (n 2) for inv(16) positive AML at our Germany institution. In addition to the analysis of minimal residual Received 3 July 1997; accepted 13 August 1997 disease (MRD), the chimerism status of patients after allo- CBFb/MYH11 fusion transcripts in patients with AML AH Elmaagacli et al 160 geneic BMT or PBPCT was studied by PCR of minisatellite one busulfan (4 mg/kg/day for 4 days), thiotepa (5 gene regions (VNTR-PCR). mg/kg/day for 2 days) and cyclophosphamide (60 mg/kg/day × 2). All transplants were performed without prior ex vivo removal of donor lymphocytes from the graft. Materials and methods Irradiated leukocyte-depleted blood products were used exclusively for blood component substitution throughout Patients the post-transplant course. Prophylaxis of acute GVHD of patients treated by allo- Ten patients with inv(16) leukemia who underwent allo- geneic transplantation consisted of short-course methotrex- geneic transplantation with bone marrow (n = 5) or periph- ate and cyclosporin A (CsA) in five patients, of CsA alone eral blood progenitor cells (n = 3), or autologous BMT (n in three patients, as shown in Table 1. = 2) at our institution were studied (Table 1). Six patients were diagnosed with de novo FAB M4Eo, and four patients were diagnosed with AML M4. The median age at diag- nosis was 31 years (range 17–40). Seven patients were male Morphologic and cytogenetics and three female. Patients were transplanted in first remission (1CR, eight AML was diagnosed according to standard FAB morpho- 9 patients), second remission (2CR, one patient), and first logic and cytochemical criteria. Chromosome analyses relapse (1rel, one patient). Two patients were transplanted were performed on bone marrow cells (24 and/or 48 h in with autologous bone marrow, and eight patients received vitro culture with GTG (G-bands obtained by trypsin and allogeneic grafts. Seven donor/recipient pairs were matched stained with Giemsa)). In all patients a pericentric inversion at the HLA-A, B, C and DR loci and were nonreactive in 16 could be demonstrated prior to transplant. mixed lymphocyte culture (MLC), and one patient (UPN 936) received a graft from an antigen-mismatched unrelated donor (one mismatch of six). All recipients of allogeneic Isolation of RNA and cDNA synthesis and reverse transplantation except one received grafts from family transcription donors. BM or blood samples were studied 1 month before transplantation and 1 to 64 months after transplant. The RNA was prepared from fresh or cyropreserved peripheral median time to last follow-up for all patients was 6 months. blood cells or BM buffy coat cells, Kasumi-1 and K562 Approval for this study was obtained from the Institutional cells provided negative controls for RT-PCR. Blood from Review Board on Medical Ethics at the Essen University a patient (UPN 799) with a CBFb/MYH11 fusion transcript Hospital. All patients gave informed consent before was used as a positive control. RNA was extracted by the material was obtained. acid guanidium/phenol/chloroform method.10 For each PCR, cDNA was synthesized from 2 mg of total RNA with 200 U Moloney murine leukemia virus (MoMuLV) reverse Conditioning regimens and GVHD prophylaxis transcriptase (Gibco-BRL, Gaithersburg, MD, USA) in The conditioning regimen consisted in five patients of PCR buffer (50 mmol/l KCl, 10 mmol/l Tris-HCl pH 8.3, cyclophosphamide (60 mg/kg/day × 2) and fractioned total 1.5 mmol/l MgCl2, 0.001% gelatin (Perkin Elmer Cetus, body irradiation (TBI) delivered from a cobalt source in Weiterstadt, Germany), using random hexamers (10 four daily fractions of 2.5 Gy to a total dose of 10 Gy. mmol/l) (Boehringer, Mannheim, Germany), deoxynucleo- Four patients received busulfan (4 mg/kg/day for 4 days) tide triphosphates 8dNTP; 1 mmol/l each), 20 U RNAsin followed by cyclophosphamide (60 mg/kg/day × 2), and at a final volume of 20 mlat37°C for 1 h. Table 1 Clinical characteristics of the AML patients with inv(16) No. UPN Sex Age Trans Disease GVHD Condit GVHD HLA Present status R/D stage proph regimen ac/chr constel (months) 1 176 — 17 autoBMT 1CR — Bu + CY — — Relapse/death (3) 2 189 — 40 autoBMT 1CR — Bu + CY — — Relapse/death (23) 3 469 M/F 34 BMT 1CR CsA + MTX TBI + CY —/lim de novo si/id DSF (69) 4 554 M/F 34 BMT 1CR CsA + MTX Bu + CY II/lim si/id DFS (54) 5 799 M/F 32 PBPCT 1CR CsA + MTX TBI + CY II/lim si/id Relapse/death (7) 6 856 M/M 30 BMT 1CR CsA Bu,Th,CY II/lim bro/id Death through infection (12) 7 868 F/F 25 BMT 1CR CsA TBI + CY I/lim si/id DFS (12) 8 876 F/M 36 PBPCT 2CR CsA + MTX Bu,Th,CY II/lim bro/id DFS (10) 9 882 F/F 25 BMT 1CR CsA TBI + CY IV/ext si/id DFS (10) 10 936 M/M 35 PBPCT Relap CsA + MTX TBI + CY II/— unr/MM Death through infection (3) UPN = unique patient number; R = recipient; D = donor; GVHD = graft-versus-host disease; 1CR/2CR, first/second remission; PBPCT = peripheral blood progenitor cell transplantation; BMT = bone marrow transplantation; MTX = methotrexate; CsA = cyclosporin A; TBI = total body irradiation; CY = cyclophosphamide; Bu = busulfan; Th = thiotepa; bro = brother; id = identical; unr = unrelated; si = sister; lim = limited; ext = extensive; DFS = disease-free survivor.
Load more

Recommended publications
  • Xenopus Laevis Sperm Receptor Gp69/64 Glycoprotein Is a Homolog
    Proc. Natl. Acad. Sci. USA Vol. 96, pp. 829–834, February 1999 Biochemistry Xenopus laevis sperm receptor gp69y64 glycoprotein is a homolog of the mammalian sperm receptor ZP2 JINGDONG TIAN*, HUI GONG, AND WILLIAM J. LENNARZ† Department of Biochemistry and Cell Biology and Institute for Cell and Developmental Biology, State University of New York, Stony Brook, NY 11794-5215 Contributed by William J. Lennarz, November 4, 1998 ABSTRACT Little is known about sperm-binding pro- Much less information is available on the identity of sperm teins in the egg envelope of nonmammalian vertebrate species. receptors in other, nonmammalian vertebrate species. Re- We report here the molecular cloning and characterization of cently, a Xenopus laevis sperm receptor (gp69y64) in the egg a recently identified sperm receptor (gp69y64) in the Xenopus vitelline envelope (VE) was identified (7, 8). It was shown that laevis egg vitelline envelope. Our data indicate that the gp69 the purified gp69y64 proteins, as well as their antibodies, and gp64 glycoproteins are two glycoforms of the receptor and blocked sperm binding to unfertilized eggs or to beads coupled have the same number of N-linked oligosaccharide chains but with gp69y64 proteins. It has been know for some time (9) that differ in the extent of O-glycosylation. The amino acid se- during fertilization, gp69y64 undergoes limited proteolysis. quence of the receptor is closely related to that of the mouse However, the molecular details of this cleavage have been zona pellucida protein ZP2. Most of the sequence conserva- unclear because the primary structure of gp69y64 was un- tion, including a ZP domain, a potential furin cleavage site, known.
    [Show full text]
  • Rat Zona Pellucida Sperm-Binding Protein 2 (ZP2) ELISA Kit
    Product Datasheet Rat Zona pellucida sperm-binding protein 2 (ZP2) ELISA Kit Catalog No: #EK11690 Orders: [email protected] Package Size: #EK11690-1 48T #EK11690-2 96T Support: [email protected] Description Product Name Rat Zona pellucida sperm-binding protein 2 (ZP2) ELISA Kit Brief Description ELISA Kit Applications ELISA Species Reactivity Rat (Rattus norvegicus) Other Names ZPA; zona pellucida glycoprotein 2|zona pellucida protein A|zona pellucida sperm-binding protein 2 Accession No. P48829 Storage The stability of ELISA kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition. The loss rate was determined by accelerated thermal degradation test. Keep the kit at 37C for 4 and 7 days, and compare O.D.values of the kit kept at 37C with that of at recommended temperature. (referring from China Biological Products Standard, which was calculated by the Arrhenius equation. For ELISA kit, 4 days storage at 37C can be considered as 6 months at 2 - 8C, which means 7 days at 37C equaling 12 months at 2 - 8C). Application Details Detect Range:0.312-20 ng/mL Sensitivity:0.125 ng/mL Sample Type:Serum, Plasma, Other biological fluids Sample Volume: 1-200 µL Assay Time:1-4.5h Detection wavelength:450 nm Product Description Detection Method:SandwichTest principle:This assay employs a two-site sandwich ELISA to quantitate ZP2 in samples. An antibody specific for ZP2 has been pre-coated onto a microplate. Standards and samples are pipetted into the wells and anyZP2 present is bound by the immobilized antibody.
    [Show full text]
  • Positive Darwinian Selection Drives the Evolution of Several Female Reproductive Proteins in Mammals
    Positive Darwinian selection drives the evolution of several female reproductive proteins in mammals Willie J. Swanson*†, Ziheng Yang‡, Mariana F. Wolfner*, and Charles F. Aquadro* *Department of Molecular Biology and Genetics, Biotechnology Building, Cornell University, Ithaca, NY 14853-2703; and ‡Department of Biology, University College London, 4 Stephenson Way, London NW1 2HE, United Kingdom Communicated by M. T. Clegg, University of California, Riverside, CA, December 20, 2000 (received for review May 15, 2000) Rapid evolution driven by positive Darwinian selection is a recur- neutral evolution, purifying selection, and positive diversifying rent theme in male reproductive protein evolution. In contrast, selection, respectively. This criterion has been used to demon- positive selection has never been demonstrated for female repro- strate rapid evolution of male reproductive proteins in a variety ductive proteins. Here, we perform phylogeny-based tests on three of invertebrate and vertebrate species (1–17). Recently, Wyckoff female mammalian fertilization proteins and demonstrate positive et al. (1) used the ␻ ratio and other criteria to demonstrate the selection promoting their divergence. Two of these female fertil- rapid evolution of male reproductive proteins in primates. In ization proteins, the zona pellucida glycoproteins ZP2 and ZP3, are their study, female reproductive proteins, including OGP and part of the mammalian egg coat. Several sites identified in ZP3 as ZP3, were placed within a control group of nonrapidly evolving likely to be under positive selection are located in a region genes expressed in a variety of tissues (1). To elucidate the previously demonstrated to be involved in species-specific sperm- selective forces underlying the rapid divergence of reproductive egg interaction, suggesting the selective pressure is related to proteins, it is important to analyze female, as well as male, male-female interaction.
    [Show full text]
  • Zona Pellucida Protein ZP2 Is Expressed in the Oocyte of Japanese Quail (Coturnix Japonica)
    REPRODUCTIONRESEARCH Zona pellucida protein ZP2 is expressed in the oocyte of Japanese quail (Coturnix japonica) Mihoko Kinoshita, Daniela Rodler1, Kenichi Sugiura, Kayoko Matsushima, Norio Kansaku2, Kenichi Tahara3, Akira Tsukada3, Hiroko Ono3, Takashi Yoshimura3, Norio Yoshizaki4, Ryota Tanaka5, Tetsuya Kohsaka and Tomohiro Sasanami Department of Applied Biological Chemistry, Faculty of Agriculture, Shizuoka University, 836 Ohya, Shizuoka 422-8529, Japan, 1Institute of Veterinary Anatomy II, University of Munich, Veterinaerstrasse 13, 80539 Munich, Germany, 2Laboratory of Animal Genetics and Breeding, Azabu University, Fuchinobe, Sagamihara 229-8501, Japan, 3Graduate School of Bioagricultural Sciences, Nagoya University, Furo-cho, Chikusa-ku, Nagoya 464-8601, Japan, 4Department of Agricultural Science, Gifu University, Gifu 501-1193, Japan and 5Biosafety Research Center, Foods, Drugs, and Pesticides (An-Pyo Center), Iwata 437-1213, Japan Correspondence should be addressed to T Sasanami; Email: [email protected] Abstract The avian perivitelline layer (PL), a vestment homologous to the zona pellucida (ZP) of mammalian oocytes, is composed of at least three glycoproteins. Our previous studies have demonstrated that the matrix’s components, ZP3 and ZPD, are synthesized in ovarian granulosa cells. Another component, ZP1, is synthesized in the liver and is transported to the ovary by blood circulation. In this study, we report the isolation of cDNA encoding quail ZP2 and its expression in the female bird. By RNase protection assay and in situ hybridization, we demonstrate that ZP2 transcripts are restricted to the oocytes of small white follicles (SWF). The expression level of ZP2 decreased dramatically during follicular development, and the highest expression was observed in the SWF. Western blot and immunohistochemical analyses using the specific antibody against ZP2 indicate that the 80 kDa protein is the authentic ZP2, and the immunoreactive ZP2 protein is also present in the oocytes.
    [Show full text]
  • Binding of Mouse ZP2 to Sperm Proacrosin 4129 from the Specific Activity of Labelling and Avogadro’S Constant (Bleil Et Al., 1988)
    RESEARCH ARTICLE 4127 Interactions between mouse ZP2 glycoprotein and proacrosin; a mechanism for secondary binding of sperm to the zona pellucida during fertilization Elizabeth Howes1, John C. Pascall1, Wolfgang Engel2 and Roy Jones1,* 1Signalling Programme, The Babraham Institute, Cambridge CB2 4AT, UK 2Institut fur Humangenetik, Universitat Gottingen, D-37073, Germany *Author for correspondence (e-mail: [email protected]) Accepted 7 August 2001 Journal of Cell Science 114, 4127-4136 (2001) © The Company of Biologists Ltd SUMMARY The mouse zona pellucida glycoprotein, mZP2, is thought complementary binding sites on proacrosin/acrosin in to be the secondary receptor on eggs for retention of solid-phase binding assays. The same competitors also acrosome-reacted sperm during fertilization. Here, we displace attached sperm from the zona pellucida of eggs in present evidence that one of its complementary binding an in vitro fertilization system. This combination of genetic, proteins on sperm is proacrosin/acrosin. mZP2 binds to biochemical and functional data supports the hypothesis proacrosin null sperm considerably less effectively than to that mZP2-proacrosin interactions are important for wild-type sperm. Binding is mediated by a strong ionic retention of acrosome-reacted sperm on the egg surface interaction between polysulphate groups on mZP2 and during fertilization. Safe mimetics of suramin have basic residues on an internal proacrosin peptide. The potential as non-steroidal antifertility agents. stereochemistry of both sulphate groups and basic amino acids determines the specificity of binding. Structurally relevant sulphated polymers and suramin, a Key words: Fertilization, Proacrosin, Zona Pellucida Glycoprotein polysulphonated anticancer drug, compete with mZP2 for mZP2, Secondary binding, Mouse INTRODUCTION consensus of opinion on the nature of the primary mZP3- binding molecules on the mouse sperm surface.
    [Show full text]
  • ZP2 Pathogenic Variants Cause in Vitro Fertilization Failure and Female Infertility
    © American College of Medical Genetics and Genomics ARTICLE ZP2 pathogenic variants cause in vitro fertilization failure and female infertility Can Dai, PhD1, Liang Hu, MD,PhD1,2,3,4, Fei Gong, MD, PhD1,2,3, Yueqiu Tan, PhD1,2,3, Sufen Cai, MD1,2, Shuoping Zhang, MD1,2, Jing Dai, MS1,2, Changfu Lu, PhD1,2,3, Jing Chen, MS2, Yongzhe Chen, MS2, Guangxiu Lu, MD1,3,4, Juan Du, PhD1,2,3 and Ge Lin, MD, PhD1,2,3,4 Purpose: The oocyte-borne genetic causes leading to fertilization families. All oocytes carrying PV were surrounded by a thin ZP that failure are largely unknown. We aimed to identify novel human was defective for sperm-binding. Immunostaining indicated a lack pathogenic variants (PV) and genes causing fertilization failure. of ZP2 protein in the thin ZP. Studies in CHO cells showed that Methods: We performed exome sequencing for a consanguineous both PV resulted in a truncated ZP2 protein, which might be family with a recessive inheritance pattern of female infertility intracellularly sequestered and prematurely interacted with other characterized by oocytes with a thin zona pellucida (ZP) and ZP proteins. fertilization failure in routine in vitro fertilization. Subsequent Conclusion: We identified loss-of-function PV of ZP2 causing a PV screening of ZP2 was performed in additional eight unrelated structurally abnormal and dysfunctional ZP, resulting in fertiliza- infertile women whose oocytes exhibited abnormal ZP and similar tion failure and female infertility. fertilization failure. Expression of ZP proteins was assessed in mutant oocytes by immunostaining, and functional studies of the wild-type Genetics in Medicine (2019) 21:431–440; https://doi.org/10.1038/s41436- and mutant proteins were carried out in CHO-K1 cells.
    [Show full text]
  • Biology of Mammalian Fertilization: Role of the Zona Pellucida
    Perspectives Biology of Mammalian Fertilization: Role of the Zona Pellucida Jurrien Dean Laboratory of Cellular and Developmental Biology, National Institute ofDiabetes and Digestive and Kidney Diseases, National Institutes ofHealth, Bethesda, Maryland 20892 Introduction before approaching the ovulated egg in the oviduct (Fig. 1 A). In mammals, a series of carefully orchestrated events culmi- Motile sperm pass through the enveloping cumulus oophorus, nate in the fusion of a sperm and egg to form a one-cell zygote, which is composed of a glycosylaminoglycan matrix and cu- the obligatory precursor of all cells in the embryo. The overall mulus cells. They then bind to the zona pellucida that rate of fertilization in humans has contributed to sustained surrounds the mammalian egg (1, 2). The mouse and human increases in the world population and added urgency to the zonae pellucidae are composed of three major glycoproteins, need to develop new, effective contraceptive agents. For some, ZP1, ZP2, and ZP3. Solubilized zonae pellucidae from unfertil- however, the success rate is considerably lower, and there are ized mouse eggs (but not from two-cell embryos) can inhibit millions of infertile couples in the United States. Dramatic ad- sperm binding to ovulated eggs (3). This sperm-receptor activ- vances in reproductive biology have provided some relief for ity of the zona has been ascribed to a class of 3.9-kD 0-linked these individuals through the development of in vitro fertiliza- oligosaccharides on ZP3 (4). ZP2 has been implicated as a sec- tion techniques. Further progress requires additional under- ondary sperm receptor that binds sperm only after the induc- standing ofthe molecular basis for normal fertilization and our tion of the sperm acrosome reaction (5).
    [Show full text]
  • ZP2 Antibody Cat
    ZP2 Antibody Cat. No.: 30-070 ZP2 Antibody Specifications HOST SPECIES: Rabbit SPECIES REACTIVITY: Human Antibody produced in rabbits immunized with a synthetic peptide corresponding a region IMMUNOGEN: of human ZP2. TESTED APPLICATIONS: ELISA, WB ZP2 antibody can be used for detection of ZP2 by ELISA at 1:62500. ZP2 antibody can be APPLICATIONS: used for detection of ZP2 by western blot at 2.5 μg/mL, and HRP conjugated secondary antibody should be diluted 1:50,000 - 100,000. POSITIVE CONTROL: 1) Cat. No. 1211 - HepG2 Cell Lysate PREDICTED MOLECULAR 68 kDa WEIGHT: Properties PURIFICATION: Antibody is purified by protein A chromatography method. CLONALITY: Polyclonal CONJUGATE: Unconjugated PHYSICAL STATE: Liquid September 25, 2021 1 https://www.prosci-inc.com/zp2-antibody-30-070.html Purified antibody supplied in 1x PBS buffer with 0.09% (w/v) sodium azide and 2% BUFFER: sucrose. CONCENTRATION: batch dependent For short periods of storage (days) store at 4˚C. For longer periods of storage, store ZP2 STORAGE CONDITIONS: antibody at -20˚C. As with any antibody avoid repeat freeze-thaw cycles. Additional Info OFFICIAL SYMBOL: ZP2 ALTERNATE NAMES: ZP2, ZPA, Zp-2 ACCESSION NO.: NP_003451 PROTEIN GI NO.: 4508045 GENE ID: 7783 USER NOTE: Optimal dilutions for each application to be determined by the researcher. Background and References The zona pellucida is an extracellular matrix that surrounds the oocyte and early embryo. It is composed primarily of three or four glycoproteins with various functions during fertilization and preimplantation development. ZP2 is a structural component of the zona pellucida and functions in secondary binding and penetration of acrosome-reacted spermatozoa.
    [Show full text]
  • Three-Dimensional Structure of the Zona Pellucida
    Reviews of Reproduction (1997) 2, 147–156 Three-dimensional structure of the zona pellucida David P. L. Green Department of Anatomy and Structural Biology, School of Medical Sciences, University of Otago Medical School, PO Box 913, Dunedin, New Zealand The zona pellucida is the extracellular coat that surrounds the mammalian oocyte. It forms a spherical shell of remarkably uniform thickness (5–10 µm in eutherian mammals). The mouse is currently the largest source of data on the zona pellucida and this review is built largely on these data. The zona pellucida is composed of three proteins in both mice and humans: ZP1, ZP2 and ZP3. These proteins are glycosylated and, in mice, have mature relative molecular masses of 200 000, 120 000 and 83 000, respectively. ZP1 is a dimer of two apparently identical subunits. All three mouse proteins have been sequenced and possess transmembrane domains at their C-terminal ends coupled with furin cleavage sites immediately upstream. Sequence data have been used to provide an accurate assessment of the mole ratios of the three proteins. The ratio of ZP2:ZP3 is close to 1:1, whereas ZP1 is approximately 9% of the combined mole amounts of ZP2 and ZP3. Ultrastructural evidence suggests that the mouse zona pellucida is composed of filaments constructed by head-to-tail association of globular proteins. The co- ordinate synthesis of the three zona pellucida proteins coupled with the near 1:1 stoichiometry of ZP2 and ZP3 is consistent with a model in which ZP2–ZP3 heterodimers are the basic re- peating units of the filament, with cross-linking of filaments by dimeric ZP1.
    [Show full text]
  • Coordinate Expression of the Three Zona Pellucida Genes During Mouse Oogenesis
    Development 121, 1947-1956 (1995) 1947 Printed in Great Britain © The Company of Biologists Limited 1995 Coordinate expression of the three zona pellucida genes during mouse oogenesis Olga Epifano1,*, Li-fang Liang1, Mary Familari1, Malcolm C. Moos, Jr2 and Jurrien Dean1 1Laboratory of Cellular and Developmental Biology, NIDDK, National Institutes of Health, Bethesda, MD 20892, USA 2Laboratory of Developmental Biology, Center for Biologics Evaluation and Research, Bethesda, MD 20892, USA *Author for correspondence SUMMARY The mammalian zona pellucida is an extracellular matrix restricted to the oocyte. ZP2 transcripts, but not ZP1 or that surrounds growing oocytes, ovulated eggs and early ZP3, are detected in resting (15 µm diameter) oocytes, and embryos. The mouse zona is composed of three sulfated all three zona transcripts coordinately accumulate as glycoproteins: ZP1, ZP2 and ZP3. Each is critically oocytes begin to grow. Together they represent approxi- involved in fertilization, the postfertilization block to mately 1.5% of the total poly(A)+ RNA in 50-60 µm oocytes. polyspermy and protection of the preimplantation embryo. In the latter stages of oogenesis, their abundance declines We have previously isolated cDNAs encoding mouse ZP2 and each zona transcript is present in ovulated eggs at less and ZP3 and now report the isolation of a full-length cDNA than 5% of its maximal level. No zona transcripts were encoding ZP1. Mouse ZP1 is composed of a 623 amino acid detected above background signal in granulosa cells. We polypeptide chain with a signal peptide and a carboxyl conclude that, in mice, the three zona pellucida genes are terminal transmembrane domain, typical of all zona expressed in a coordinate, oocyte-specific manner during proteins.
    [Show full text]
  • Human Homolog of the Mouse Sperm Receptor (Human Zona Pellucida/ZP3/Oocyte-Specific Gene Expression/Cis-Acting Elements/Human Sperm Receptor) MARGARET E
    Proc. Nati. Acad. Sci. USA Vol. 87, pp. 6014-6018, August 1990 Developmental Biology Human homolog of the mouse sperm receptor (human zona pellucida/ZP3/oocyte-specific gene expression/cis-acting elements/human sperm receptor) MARGARET E. CHAMBERLIN AND JURRIEN DEAN Laboratory of Cellular and Developmental Biology, National Institute of Arthritis, Diabetes, and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892 Communicated by Christian B. Anfinsen, May 31, 1990 ABSTRACT The human zona pellucida, composed of see ref. 7). The recent cloning of mouse ZP2 and ZP3 cDNAs three glycoproteins (ZP1, ZP2, and ZP3), forms an extracel- (8-10) and the characterization of their genomic loci (8, 11, lular matrix that surrounds ovulated eggs and mediates species- 12) has provided a wealth of molecular detail on the primary specific fertilization. The genes that code for at least two of the structure of the zona proteins and their developmentally zona proteins (ZP2 and ZP3) cross-hybridize with other mam- regulated expression during oogenesis (8, 13). malian DNA. The recently characterized mouse sperm receptor Less is known about the primary structure and the func- gene (Zp-3) was used to isolate its human homolog. The human tions of the zona pellucida proteins from other species, homolog spans =18.3 kilobase pairs (kbp) (compared to 8.6 including that of human. The human zona pellucida is com- kbp for the mouse gene) and contains eight exons, the sizes of posed of three glycoproteins, ZP1 (90-110 kDa), ZP2 (64-76 which are strictly conserved between the two species. Four kDa), and ZP3 (57-73 kDa) (14, 15), at least one of which short (8-15 bp) sequences within the first 250 bp of the 5' appears to be modified following fertilization (15).
    [Show full text]
  • Sperm-Borne Phospholipase C Zeta-1 Ensures Monospermic Fertilization
    www.nature.com/scientificreports OPEN Sperm-borne phospholipase C zeta-1 ensures monospermic fertilization in mice Received: 1 September 2017 Kaori Nozawa1,2, Yuhkoh Satouh 1, Takao Fujimoto1,3, Asami Oji1,3 & Masahito Ikawa 1,2,3,4 Accepted: 3 January 2018 Sperm entry in mammalian oocytes triggers intracellular Ca2+ oscillations that initiate resumption of Published: xx xx xxxx the meiotic cell cycle and subsequent activations. Here, we show that phospholipase C zeta 1 (PLCζ1) is the long-sought sperm-borne oocyte activation factor (SOAF). Plcz1 gene knockout (KO) mouse spermatozoa fail to induce Ca2+ changes in intracytoplasmic sperm injection (ICSI). In contrast to ICSI, Plcz1 KO spermatozoa induced atypical patterns of Ca2+ changes in normal fertilizations, and most of the fertilized oocytes ceased development at the 1–2-cell stage because of oocyte activation failure or polyspermy. We further discovered that both zona pellucida block to polyspermy (ZPBP) and plasma membrane block to polyspermy (PMBP) were delayed in oocytes fertilized with Plcz1 KO spermatozoa. With the observation that polyspermy is rare in astacin-like metalloendopeptidase (Astl) KO female oocytes that lack ZPBP, we conclude that PMPB plays more critical role than ZPBP in vivo. Finally, we obtained healthy pups from male mice carrying human infertile PLCZ1 mutation by single sperm ICSI supplemented with Plcz1 mRNA injection. These results suggest that mammalian spermatozoa have a primitive oocyte activation mechanism and that PLCζ1 is a SOAF that ensures oocyte activation steps for monospermic fertilization in mammals. At mammalian fertilization, sperm entry causes Ca2+ oscillations, repetitive acute increases and decreases in cytosolic Ca2+ levels lasting for several hours in human and mouse eggs, which trigger not only resumption of the meiotic cell cycle but also block polyspermy, the entry of multiple sperm heads into the ooplasm1.
    [Show full text]